Objective Genome-wide association studies (GWAS) have linked many single nucleotide polymorphisms (SNPs) to the outcomes of a variety of liver diseases. The aim of the present study was to evaluate the association of several candidate SNPs with the risk and severity of cirrhosis due to chronic hepatitis B in a Chinese population. Methods A total of 714 Chinese participants with persistent HBV infection were studied. Patients were divided into cirrhotic (n = 429) and non-cirrhotic (n = 285) groups based on clinical and pathological evidence. The progression rate and severity of liver cirrhosis were evaluated with an arbitrary t-score system. Genotypes of six SNPs in five candidate genes were detected with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). The genotypic distributions of the SNPs were compared between the age-matched cirrhotic and non-cirrhotic subjects. The association between the risk of SNPs and the severity and progression rate of cirrhosis was further analyzed. Results Rs2679757 polymorphism of the antizyme inhibitor 1 (AZIN1) gene and Rs886277 in the transient receptor potential cation channel subfamily M, member 5 gene (TRPM5) were found to be associated with cirrhosis risk in CHB. They were also correlated with the overall severity and progression rate of cirrhosis. Genotype frequencies of other SNPs were not different between the cirrhosis and non-cirrhosis groups. Conclusions AZIN1 rs2679757 and TRPM5 rs886277 are associated with the risk and the progression rate of HBV-related liver fibrosis in Chinese patients. The emerging SNPs associated with cirrhosis prognosis warrant further clinical validation in other CHB cohorts or ethnic groups, and merit mechanistic studies to reveal their roles in fibrosis progression.
B ased on data from Poynard et al, patients with chronic hepatitis C have highly variable rates of disease progression; some progress rapidly, others are slow, and on average the progression to cirrhosis requires approximately 30 years.
1 Host genetic factors may contribute significantly to the variable risk of fibrosis progression to cirrhosis. Single nucleotide polymorphisms (SNPs) are the stable replacement of a single nucleotides in a human gene. A SNP is the most common genetic variant in humans, appearing in more than 1% of the population. SNPs may affect biological processes and disease development if they impact on the function of relevant genes. 2, 3 In recent 3 Celera Corporation, Alameda, CA, USA Correspondence: Jin-sheng Guo, E-mail: guo.jinsheng@zs-hospital.sh.cn decades, genome-wide association studies (GWAS) and candidate gene association studies have been widely performed to delineate the genetic impact of SNPs on human liver diseases. 4 Notably, Huang et al identified 9 SNPs residing in 9 genes that are associated with liver fibrosis progression in Caucasian patients infected with hepatitis C virus (HCV). Cirrhosis risk scores (CRS) built on 7 of these SNPs were predictive for fibrosis progression in Caucasian chronic hepatitis C patients in longitudinal studies. [5] [6] [7] [8] However, few studies have investigated the roles of host gene polymorphisms on the progression of HBV-related liver cirrhosis, which, like hepatitis C, is a public health threat worldwide and is especially endemic in China. [9] [10] [11] As the biology of chronic hepatitis B fibrogenesis is similar to that of hepatitis C or other etiologies of liver diseases, these different diseases may share common genetic
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Polymorphisms of AZIN1 rs2679757 and TRPM5 rs886277 are Associated with Cirrhosis Risk in Chinese Patients with Chronic Hepatitis B risk factors for fibrosis progression. Therefore, the present study was designed to evaluate the association of specific cirrhosis risk SNPs reported in the recent studies in Caucasian hepatitis C patients with the risk of cirrhosis among Chinese with chronic HBV infection.
METHODS

Study population
Total of 988 HBV-infected subjects were collected from Zhongshan Hospital, Fudan University between March 2009 and January 2011 and a total of 714 Chinese subjects with persistent HBV infection were studied. They were all Chinese Han subjects from an epidemic region of HBV, eastern coastal region of China. The study was approved by the ethical committee of the hospital and was registered on the Chinese Clinical Trials Register (http://www.chictr.org) numbered ChiCTR-ONC-00000439. The protocol conformed to the provisions of the Declaration of Helsinki (as revised in Tokyo, 2004) . Informed consent was obtained from all subjects.
Clinical information and grouping of the patients
Information including hepatitis B history, alcohol consumption, serum HBV markers, liver function test, prothrombin time, platelets count, liver imaging (computed tomography or magnetic resonance imaging) and liver histology if available, was collected to establish the diagnosis and judge the severity of HBV-related liver disease. The status of their chronic HBV infection is indicated by HBV surface antigen positive with or without e antigen, and high or low HBV DNA load. The 714 chronic HBV infected subjects were divided into cirrhotic and the noncirrhotic groups. The cirrhotic patients were defined by evident liver cirrhosis clinically or histologically, the presence of decompensated cirrhosis based on presence of ascites, variceal bleeding, encephalopathy, spontaneous bacterial peritonitis, or Child-Pugh grade of B or C. The non-cirrhotic patients were defined as inactive HBV carriers, without cirrhosis-related clinical abnormalities or exam findings. Patients with evidence of chronic hepatitis C, autoimmune liver diseases, nonalcoholic steatohepatitis, drug-induced liver disease, Wilson's disease and serious clinical condition of other organs were excluded. Patients with alcohol consumption of > 40 g/day in males and > 20 g/day in females for at least 5 years were deemed alcoholics and excluded from the study. Patients with long-term anti-HBV therapy were also excluded.
The overall severity of liver cirrhosis was arbitrarily scored with a t-score system containing items included in Child-Pugh grade, platelet count, and the occurrence of decompensate complications of liver cirrhosis, with a range from 10 to 27 (Table 1 ). The progression rate of liver cirrhosis was expressed as a devided t-score by the duration of infection (Table 1) .
Six SNPs in five genes reported by previous studies that were associated with cirrhosis risk in hepatitis C patients in Caucasian were selected (Table  2 ). Among them, there are SNPs within aquaporin 2 (AQP2), antizyme inhibitor 1 (AZIN1), degenerative spermatocyte homolog 1, lipid desaturase (DEGS1), toll-like receptor 4 (TLR4), transient receptor potential cation channel subfamily M, member 5 (TRPM5). Details of the SNP location (missense, synonymous, promoter, intronic or other changes), known function or potential biological impact of the SNPs are also listed in Table 2. 14-22
Preparation of DNA samples From each subject, 2 ml blood was collected in an EDTA-containing tube. Genomic DNA was extracted with QIAamp DNA Blood Midi Kit (Qiagen, Valencia, CA, USA). DNA samples were analyzed by nucleic acid spectrophotometer and gel electrophoresis to 
SNPs detection
SNPs were genotyped using matrix assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS), which determines the allelespecific primer extension products with Sequenom's MassARRAY system and iPLEX technology (Sequenom, San Diego, CA, USA; www.sequenom.com).
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After laser desorption/ionization, automated spectral acquisition analysis was performed and the spectral data was saved to the MassARRAY database.
Statistical analysis
The parametric Student t-test and the non-parametric Wilcoxon rank-sum test, Pearson χ 2 test, or Fisher's test were utilized to assess differences in the mean data between groups for the characteristics and liver function profiles of the studied populations. The χ 2 test was also used in the evaluation of Hardy-Weinberg equilibrium. Binary logistic regression analysis was performed to determine the adjusted significance of the genotypic distribution of each SNP between the cirrhotic and non-cirrhotic groups, where age and sex were covariables. Each statistically significant SNP in univariate analysis was further assessed with logistic regression analysis using the dominant, recessive and additive genetic models, and the odds ratio (OR) and 95% confidence interval (CI) were calculated. Furthermore, the association of the significant SNPs with the severity and the progression rate of cirrhosis were also analyzed with χ 2 test and logistic regression analysis. Statistics was performed with SPSS version 15.0 software (SPSS, Chicago, IL, USA). P value < 0.05 was considered to be statistically significant.
RESULTS
Population characteristics
The characteristics of the 714 subjects in the study were shown in Table 3 . There was no difference between the cirrhotic and non-cirrhotic groups in mean age and age stratification. There is a higher ratio of male gender in the cirrhotic group when compared with the non-cirrhotic group. The blood tests and Child-Pugh grades suggested apparent liver decompensation in the , and 10 to 13 (sec), respectively. Data were expressed as mean ± standard deviation. 20.4 (μmol/L), < 75 (U/L), 35 to 52 (g/L), and 10 to 13 (sec), respectively. Data were expressed as mean ± standard deviation.
cirrhotic group (Table 3) .
Association between individual SNPs and liver cirrhosis
Also a highly variable rate of cirrhosis progression was observed in the group of hepatitis B patients ( Figure  1 ). Minor allele frequency (MAF) of each SNP was shown in Table 4 . The genotypic distributions for the polymorphic sites were in Hardy-Weinberg equilibrium in this population (P > 0.05). Two loci, rs4986791 in TLR4 gene and rs62522600 in AZIN1 gene had no polymorphisms in the Chinese population. Rs17740066 in STXBP5L gene had an MAF < 5%. Some of the other alleles also showed differences from those reported in the NCBI SNP database (http://www.ncbi. nlm.nih.gov/projects/SNP/) in Caucasian (Table 4) .
There was no significant association between these SNPs and liver cirrhosis except AZIN1 rs2679757 and TRPM5 rs886277 (Table 5 ). Regression analysis with adjustment for age and sex revealed that rs2679757 genotypes were associated with a significant risk of liver cirrhosis with the use of either a dominant or an additive genetic model for the G risk allele. Similarly, rs886277 genotypes in the TRPM5 gene were associated with liver cirrhosis risk in the recessive model for the risk C allele ( Table 6 ).
Correlation of AZIN1 and TRPM5 SNPs with the progression rate and severity of liver cirrhosis AZIN1 rs2679757 and TRPM5 rs886277 were also correlated well with t-score and associated the severity of liver cirrhosis (Figure 2) . Patients with the risk of SNPs also had a higher progression rate to liver cirrhosis as expressed by progression rate (t-score/ duration of infection) (Figure 3) .
In a further analysis for the association of rs2679757 and rs886277 polymorphisms with the severity of cirrhosis judged by the Child-Pugh classification, the GG homozygote and AG heterozygote (GG + AG) of AZIN1 rs2679757 as a risk of SNP were found to have 
DISCUSSION
HBV infection is a public health threat worldwide, with up to two billion people harboring serological evidence of past or present infection, and 360 million with chronic infection.
9 HBV infection is endemic highly in China with an HBV surface antigen sero-positive rate as high as 5%-12%. 10 The natural history of HBV infection varies from spontaneous recovery post infection, chronic asymptomatic carrier, to persistent infection with progression of fibrosis to decompensated cirrhosis and hepatocellular carcinoma, which confer a high mortality rate and heavy economic burden.
11-13
Besides factors such as alcohol abuse, gender, age, and viral genotypes contributing to this high variability, host genetic factors could be an important determinant predicting progression to cirrhosis in hepatitis B. A single nucleotide polymorphism (SNP) is the most common genetic mutation in humans and may change the amino acid sequence and protein function if present within the coding region of genes. Alternatively, SNPs may alter the gene's expression at the level of RNA transcription, splicing or protein translation if situated in the intronic or intergenic regulatory region. The identification of disease-related gene determinants may assist in the prediction of individual risk of disease progression, help to understand the pathophysiologic mechanisms of the diseases, and provide insight into the establishment of a personalized treatment strategy.
The present study provides the first evidence that the rs2679757 polymorphism in AZIN1 gene and rs886277 in TRPM5 gene were associated with the development and severity of cirrhosis in hepatitis B patients. Functionally, ornithine decarboxylase (ODC) is the first and rate-limiting enzyme in the biosynthesis of polyamines. AZIN1 titrates intracellular polyamine levels by antagonizing Az function, allowing ODC to escape Az mediated degradation and stimulate cellular polyamine uptake. 15 In a recent paper, 25 the minor allelic SNP variant rs62522600 in the twelfth exon of AZIN1 favors the expression of a novel splice form, AZIN1 SV2, that inhibits the expression of fibrogenic genes in hepatic stellate cells via a novel, polyamine independent pathway. 25 However, this locus was not identified among diverse genotypes in Chinese (data not shown). The polymorphic nature of the AZIN1 gene may modulate individual responses to liver damage and serve as a common functional SNP in HBV-and HCV-induced hepatic fibrogenesis. The presence of this SNP in the intronic region of AZIN1 gene may alter the gene expression and function by creating an alternative splice site that affects post-transcriptional regulation of the gene. TRPM5 is one member of the melastatin subfamily of transient receptor potential ion channels that are widely distributed in mammalian tissues. 22 It is a calcium-activated cation channel that functions in taste signal transduction. 26 The specific physiological function of TRPM5 in liver is unknown. The variant rs886277 leading to a missense change in amino acid sequence may influence the biological function of the TRPM5 protein.
In this study, a reliable medium-throughout genotyping platform using the Sequenom Mass ARRAY system was established for testing gene variants. This methodology allows simultaneous determination of multiple SNPs in one set with hundreds of samples, and has the potential to generate convenient polygenic tests useful in the clinical setting, and for testing the potential CRS signature built on risk of SNPs.
In conclusion, two polymorphisms among 6 candidate SNPs, rs2679757 in AZIN1 gene and rs886277 in TRPM5 gene, were associated with liver cirrhosis risk in Chinese hepatitis B patients. These SNPs related to cirrhosis warrant further basic investigation and clinical validation in hepatitis B. Larger efforts including research by using GWAS are needed to generate and validate CRS signatures specifically for Chinese hepatitis B patients.
